Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
AMRX —
AMNEAL PHARMACEUTICALS INC
CUSIP: 03168L105 · Held by 2 superinvestors · Combined value: $78,020,926
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $77,814,286 | 6,175,737 | ADD | +423,038 |
| 2 | Jim Simons | 0.0% | $206,640 | 16,400 | REDUCE | -73,500 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +423,038 | +7.4% |
| Jim Simons | REDUCE | -73,500 | -81.8% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +12,817 | +0.2% |
| Jim Simons | REDUCE | -338,100 | -79.0% |
Who Owns AMRX? Superinvestor Holdings
AMNEAL PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $78 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.